Active Ingredient: Contains 500 mg of tranexamic acid, a synthetic derivative of the amino acid lysine.
Formulation: It is an oral tablet formulation designed to be taken by mouth.
Advantages
Effective Hemostatic Agent: Highly effective in reducing or preventing excessive bleeding by stabilizing blood clots.
Oral Convenience: Allows for easy and non-invasive administration, suitable for long-term or home use.
Uses
Menorrhagia (Heavy Menstrual Bleeding): A primary indication for reducing excessive blood loss during menstruation.
Prevention and Treatment of Hemorrhage: Used to prevent or treat bleeding in various clinical situations, including dental procedures (e.g., in patients with bleeding disorders), nosebleeds, and after surgery (e.g., prostatectomy, tonsillectomy).
Nature
Antifibrinolytic Agent: Tranexamic acid primarily functions as an antifibrinolytic agent, meaning it inhibits the breakdown of blood clots.
Mechanism of Action: It competitively inhibits the activation of plasminogen to plasmin, and to a lesser extent, directly inhibits plasmin. Plasmin is the enzyme responsible for breaking down fibrin (the meshwork of a clot), thereby promoting clot stability and reducing bleeding.
Storage
Temperature: Store Tranexamic Acid Tablets 500 mg at controlled room temperature, typically between 20∘C to 25∘C (68∘F to 77∘F).
Protection: Keep the tablets in their original, tightly closed container or blister pack, protected from light and moisture.
